Home › Companies › MIRATI THERAPEUTICS INC. › 2023-2024
Compiled from SEC Form N-PX filings and MIRATI THERAPEUTICS INC.’s Form 8-K, filed December 13, 2023 (Item 5.07 on EDGAR). Page generated October 18, 2026.
Meeting of December 13, 2023: 3 items on MIRATI THERAPEUTICS INC.’s Form 8-K, filed December 13, 2023: 3 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Proxy season: 2023-2024
Explore MIRATI THERAPEUTICS INC. in the interactive database Compare manager voting policies
These tallies are MIRATI THERAPEUTICS INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed December 13, 2023 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| 1. The Merger Proposal | 52,217,230 | 137,341 | 16,524 | -- | 0 | 99.7% | Not verified | — |
| 2. The Compensation Proposal | 39,006,088 | 13,335,289 | 29,718 | -- | 0 | 75% | Not verified | — |
| 3. The Adjournment Proposal | 48,128,381 | 4,221,145 | 21,569 | -- | 0 | 92% | Not verified | — |
Source: MIRATI THERAPEUTICS INC., Form 8-K, filed with the SEC on December 13, 2023 — read the filing on EDGAR.
Each item below shows how the 252 asset managers that disclosed a MIRATI THERAPEUTICS INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of MIRATI THERAPEUTICS INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 2 wordings of this item as funds reported it.
100% of fund votes cast · no official result
Description as filed by funds: To adopt the Agreement and Plan of Merger (the "Merger Agreement"), dated October 8, 2023, by and among Mirati Therapeutics, Inc. ("Mirati"), Bristol-Myers Squibb Company ("Parent") and Vineyard Merger Sub Inc., a wholly owned subsidiary of Parent ("Merger Sub"), including the form of contingent value rights agreement to be entered into at or immediately prior to the effective time of the Merger by Parent and a rights agent reasonably acceptable to Mirati, pursuant to which Merger Sub will merge with and into Mirati (the "Merger "), with Mirati surviving the Merger as a wholly owned subsidiary of Parent.
The 66 asset managers below reported 13,008,638 for, 13,571 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,615,722 | 0 | 0 | 0 | For |
| State Street | 2,090,093 | 0 | 0 | 0 | For |
| BlackRock | 1,397,419 | 0 | 0 | 0 | For |
| Fidelity | 872,528 | 0 | 0 | 0 | For |
| Dimensional | 516,728 | 0 | 0 | 0 | For |
| MERGER FUND | 401,962 | 0 | 0 | 0 | For |
| Calamos | 277,972 | 0 | 0 | 0 | For |
| T. Rowe Price | 266,604 | 0 | 0 | 0 | For |
| TIAA | 251,174 | 0 | 0 | 0 | For |
| New York Life | 239,913 | 0 | 0 | 0 | For |
| ARBITRAGE FUNDS | 202,267 | 0 | 0 | 0 | For |
| Jackson National | 100,902 | 0 | 0 | 0 | For |
| Virtus | 79,321 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 71,719 | 0 | 0 | 0 | For |
| Aberdeen | 65,490 | 0 | 0 | 0 | For |
| AltShares Trust | 61,010 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 60,000 | 0 | 0 | 0 | For |
| Guggenheim | 40,730 | 0 | 0 | 0 | For |
| Brighthouse | 37,913 | 0 | 0 | 0 | For |
| JPMorgan | 35,906 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 32,758 | 0 | 0 | 0 | For |
| Lincoln Financial | 28,059 | 0 | 0 | 0 | For |
| Nushares ETF Trust | 24,978 | 0 | 0 | 0 | For |
| AllianceBernstein | 23,787 | 0 | 0 | 0 | For |
| Transamerica | 22,577 | 0 | 0 | 0 | For |
Showing the 25 largest of 66 asset managers. See all 66 in the interactive database.
Combines 2 wordings of this item as funds reported it.
100% of fund votes cast · no official result
Description as filed by funds: To adopt Agreement & Plan of Merger ("Merger Agreement"), dated 10/8/2023, by and among Mirati Therapeutics, Inc., Bristol- Myers Squibb Company ("Parent") and Vineyard Merger Sub Inc., a wholly owned subsidiary of Parent ("Merger Sub"), including the form of contingent value rights agreement to be entered into at or immediately prior to effective time of the Merger by Parent & a rights agent reasonably acceptable to Mirati, pursuant to which Merger Sub will merge with & into Mirati ("Merger"), with Mirati surviving the Merger as a wholly owned subsidiary of Parent.
The 14 asset managers below reported 432,818 for. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Charles Schwab | 347,560 | 0 | 0 | 0 | For |
| SEI | 15,086 | 0 | 0 | 0 | For |
| Morningstar Funds Trust | 14,831 | 0 | 0 | 0 | For |
| Gabelli | 14,000 | 0 | 0 | 0 | For |
| Neuberger Berman | 11,512 | 0 | 0 | 0 | For |
| Equitable | 9,000 | 0 | 0 | 0 | For |
| Nationwide | 8,810 | 0 | 0 | 0 | For |
| GDL FUND | 7,000 | 0 | 0 | 0 | For |
| Comstock Funds, Inc. | 2,250 | 0 | 0 | 0 | For |
| RBB FUND, INC. | 1,104 | 0 | 0 | 0 | For |
| Prudential/PGIM | 936 | 0 | 0 | 0 | For |
| NEW COVENANT FUNDS | 429 | 0 | 0 | 0 | For |
| Adviser Managed Trust | 268 | 0 | 0 | 0 | For |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC | 32 | 0 | 0 | 0 | For |
Combines 2 wordings of this item as funds reported it.
76% of fund votes cast · no official result
Description as filed by funds: TO APPROVE THE ADJOURNMENT OF THE SPECIAL MEETING TO A LATER DATE OR DATES, IF NECESSARY OR APPROPRIATE, TO SOLICIT ADDITIONAL PROXIES IF THERE ARE INSUFFICIENT VOTES TO ADOPT THE MERGER AGREEMENT AT THE TIME OF THE SPECIAL MEETING.
The 78 asset managers below reported 10,194,573 for, 3,247,052 against, 13,571 abstained. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 5,615,722 | 0 | 0 | 0 | For |
| State Street | 0 | 2,090,093 | 0 | 0 | Against |
| BlackRock | 1,397,419 | 0 | 0 | 0 | For |
| Fidelity | 44,363 | 828,165 | 0 | 0 | Mixed |
| Dimensional | 516,728 | 0 | 0 | 0 | For |
| MERGER FUND | 401,962 | 0 | 0 | 0 | For |
| Charles Schwab | 347,560 | 0 | 0 | 0 | For |
| Calamos | 277,972 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 266,604 | 0 | 0 | Against |
| TIAA | 251,174 | 0 | 0 | 0 | For |
| New York Life | 239,913 | 0 | 0 | 0 | For |
| ARBITRAGE FUNDS | 202,267 | 0 | 0 | 0 | For |
| Jackson National | 100,902 | 0 | 0 | 0 | For |
| Virtus | 79,321 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 71,719 | 0 | 0 | 0 | For |
| Aberdeen | 65,490 | 0 | 0 | 0 | For |
| AltShares Trust | 61,010 | 0 | 0 | 0 | For |
| Delaware/Macquarie | 60,000 | 0 | 0 | 0 | For |
| Guggenheim | 40,730 | 0 | 0 | 0 | For |
| Brighthouse | 385 | 37,528 | 0 | 0 | Against |
| JPMorgan | 35,906 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 32,758 | 0 | 0 | 0 | For |
| Lincoln Financial | 28,059 | 0 | 0 | 0 | For |
| Equitable | 14,009 | 0 | 13,571 | 0 | Mixed |
| Nushares ETF Trust | 24,978 | 0 | 0 | 0 | For |
Showing the 25 largest of 78 asset managers. See all 78 in the interactive database.
Combines 9 wordings of this item as funds reported it.
0.6% of fund votes cast · no official result
Description as filed by funds: To approve, by non-binding, advisory vote, compensation that may be paid or become payable by Mirati to its named executive officers in connection with the Merger.
The 248 asset managers below reported 35,086,644 for, 6,702,959,858 against, 350 abstained, 2,211 unknown. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| AQR Arbitrage LLC | 0 | 3,484,000,000 | 0 | 0 | Against |
| Maryland State Retirement & Pension System | 0 | 2,904,000,000 | 0 | 0 | Against |
| Meeder Advisory Services, Inc. | 0 | 279,000,000 | 0 | 0 | Against |
| New York Life | 0 | 23,239,913 | 0 | 0 | Against |
| EcoR1 Capital, LLC | 6,757,519 | 0 | 0 | 0 | For |
| RTW INVESTMENTS, LP | 6,112,493 | 0 | 0 | 0 | For |
| Vanguard | 5,690,245 | 0 | 0 | 0 | For |
| Avoro Capital Advisors LLC | 4,992,830 | 0 | 0 | 0 | For |
| State Street | 4,833,069 | 16,616 | 0 | 0 | For |
| BlackRock | 70,378 | 3,080,681 | 0 | 0 | Against |
| FARALLON CAPITAL MANAGEMENT LLC | 1,488,964 | 0 | 0 | 0 | For |
| Paradigm Biocapital Advisors LP | 1,293,144 | 0 | 0 | 0 | For |
| Fidelity | 0 | 1,058,334 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 904,000 | 0 | 0 | Against |
| Rock Springs Capital Management LP | 0 | 835,776 | 0 | 0 | Against |
| Charles Schwab | 0 | 695,120 | 0 | 0 | Against |
| T. Rowe Price | 0 | 641,095 | 0 | 0 | Against |
| Candriam S.C.A. | 0 | 611,738 | 0 | 0 | Against |
| Dimensional | 0 | 602,191 | 0 | 0 | Against |
| Affinity Asset Advisors, LLC | 427,444 | 0 | 0 | 0 | For |
| MERGER FUND | 401,962 | 0 | 0 | 0 | For |
| AllianceBernstein | 0 | 382,693 | 0 | 0 | Against |
| ARMISTICE CAPITAL, LLC | 372,928 | 0 | 0 | 0 | For |
| Pentwater Capital Management LP | 0 | 356,832 | 0 | 0 | Against |
| Melqart Asset Management (UK) Ltd | 353,637 | 0 | 0 | 0 | For |
Showing the 25 largest of 248 asset managers. See all 248 in the interactive database.
94% of fund votes cast · no official result
The 3 asset managers below reported 683,237 for, 39,832 against. The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 683,237 | 0 | 0 | 0 | For |
| JPMorgan | 0 | 39,333 | 0 | 0 | Against |
| Desjardins Global Asset Management Inc. | 0 | 499 | 0 | 0 | Against |
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported.
| # | Asset manager | Shares voted |
|---|---|---|
| 1 | Vanguard | 5,615,722 |
| 2 | State Street | 2,090,093 |
| 3 | BlackRock | 1,397,419 |
| 4 | Fidelity | 872,528 |
| 5 | Dimensional | 516,728 |
| 6 | MERGER FUND | 401,962 |
| 7 | Charles Schwab | 347,560 |
| 8 | Calamos | 277,972 |
| 9 | T. Rowe Price | 266,604 |
| 10 | TIAA | 251,174 |
| # | Asset manager | Shares voted |
|---|---|---|
| 1 | AQR Arbitrage LLC | 3,484,000,000 |
| 2 | Maryland State Retirement & Pension System | 2,904,000,000 |
| 3 | Meeder Advisory Services, Inc. | 279,000,000 |
| 4 | New York Life | 23,000,000 |
| 5 | EcoR1 Capital, LLC | 6,757,519 |
| 6 | RTW INVESTMENTS, LP | 6,112,493 |
| 7 | Avoro Capital Advisors LLC | 4,992,830 |
| 8 | State Street | 2,759,592 |
| 9 | BlackRock | 1,753,640 |
| 10 | FARALLON CAPITAL MANAGEMENT LLC | 1,488,964 |
Shown as share counts, not percentages: no shares-outstanding figure has been matched to MIRATI THERAPEUTICS INC. for the 2023-2024 season, so there is no denominator to divide by.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.
At MIRATI THERAPEUTICS INC.'s shareholder meeting held December 13, 2023, in the 2023-2024 proxy season, 252 asset managers reported how they voted in their SEC Form N-PX filings, covering 916 separate fund positions. Their filings are grouped here into 5 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. MIRATI THERAPEUTICS INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To approve, by non-binding, advisory vote, compensation that may be paid or become payable by… — the reporting funds cast 0.6% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.
MIRATI THERAPEUTICS INC. proxy season coverage: 2023-2024 (this page).
Download data (CSV): ballot items · votes by manager · column guide.